Journey Medical Corporation
DERM
$7.69
$0.283.78%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.04% | -5.18% | -8.73% | -7.59% | -4.24% |
| Total Other Revenue | -- | -94.81% | -94.86% | -94.88% | -100.00% |
| Total Revenue | 2.82% | -27.40% | -29.69% | -29.11% | -27.69% |
| Cost of Revenue | -3.94% | -19.45% | -23.26% | -19.46% | -34.96% |
| Gross Profit | 5.99% | -30.23% | -32.20% | -33.03% | -23.68% |
| SG&A Expenses | 11.45% | 17.95% | 8.49% | -8.44% | -16.79% |
| Depreciation & Amortization | 6.57% | 18.02% | 33.53% | 55.72% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.37% | -16.28% | -20.52% | -10.63% | -12.60% |
| Operating Income | 69.50% | -422.98% | -1,377.45% | -1,378.22% | -164.11% |
| Income Before Tax | 53.09% | -909.87% | -109.29% | -302.29% | -48.73% |
| Income Tax Expenses | -3.97% | -45.25% | -72.40% | -72.40% | 16.67% |
| Earnings from Continuing Operations | 52.75% | -1,136.54% | -99.64% | -280.79% | -48.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.75% | -1,136.54% | -99.64% | -280.79% | -48.45% |
| EBIT | 69.50% | -422.98% | -1,377.45% | -1,378.22% | -164.11% |
| EBITDA | 91.05% | -154.55% | -179.84% | -311.97% | -458.55% |
| EPS Basic | 60.71% | -486.55% | -100.61% | -213.31% | -28.41% |
| Normalized Basic EPS | 63.18% | -489.60% | -4,616.95% | -1,479.62% | -80.04% |
| EPS Diluted | 60.48% | -2,396.82% | -27.23% | -111.31% | -11.76% |
| Normalized Diluted EPS | 63.18% | -24,763.64% | -260.49% | -382.96% | -48.73% |
| Average Basic Shares Outstanding | 16.70% | 14.17% | 12.80% | 11.90% | 9.76% |
| Average Diluted Shares Outstanding | 16.70% | 10.41% | 8.99% | 8.02% | 5.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |